Member State mechanism

Review of the Member State mechanism on substandard/spurious/falsely-labelled/falsified/counterfeit (SSFFC) medical products


In order to protect public health and promote access to affordable, safe, efficacious and quality medical products, the Sixty-fifth World Health Assembly adopted resolution WHA65.19 (2012), in which it decided to establish a Member State mechanism whose general goal is to promote effective collaboration among Member States and the Secretariat, for the prevention, detection and response to substandard/spurious/falsely-labelled/falsified/counterfeit (SSFFC) medical products and associated activities. 


In line with the terms of reference of the Member State mechanism, the WHO Evaluation Office is conducting a review of the mechanism in order to gather evidence on its progress. The aim of the review is to estimate the extent to which the mechanism has progressed in achieving its objectives; to identify gaps and remaining challenges; and to make recommendations on the way forward. The scope of the review will cover the implementation of the eight strategies and action areas defined in the work plan of the Member State mechanism (document A/MSM/2/6, Annex 2), together with their relationship with the achievement of the objectives of the mechanism, and will cover the period 2012-2016. The findings and recommendations of the review will be presented to the Seventieth World Health Assembly in May 2017.


We write to you in your capacity as a nongovernmental organization in official relations with WHO and, for those of you for whom the mechanism is relevant to your work, you are invited to participate in a global electronic survey, which will be open until 31 January 2017.  Should you wish to participate in this survey, we invite you to contact the Secretary of PTF: Ten adres pocztowy jest chroniony przed spamowaniem. Aby go zobaczyć, konieczne jest włączenie w przeglądarce obsługi JavaScript.

Any information that you provide will be for evaluation purposes only. The review is being administered in accordance with all international and national privacy provisions and laws. All responses will be treated in confidence and your specific survey responses will contribute to a broader analysis together with the inputs from Member States and other stakeholders, and therefore will not be attributed to you or your organization in the report that will result from this review.


Detailed information on all activities and products of the mechanism can be accessed through the following link:


  • Utworzono .


Polskie Towarzystwo Farmakologiczne jest stowarzyszeniem naukowym działającym od 1965 roku. Statutowym celem Towarzystwa jest organizowanie i popieranie wszelkich czynności zmierzających do rozwoju badań i prac naukowych w zakresie farmakologii doświadczalnej i klinicznej oraz toksykologii, zrzeszenie osób pracujących w tych dziedzinach i upowszechnienie osiągnięć naukowych odpowiednich gałęzi nauki, reprezentowanie polskiej farmakologii i toksykologii w kraju i zagranicą.

Copyright © 2016 Polskie Towarzystwo Farmakologiczne. Wszelkie prawa zastrzeżone.